ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $901,000 | +95.4% | 147,189 | 0.0% | 0.16% | +49.1% |
| Q2 2022 | $461,000 | -45.0% | 147,189 | 0.0% | 0.11% | -46.5% |
| Q1 2022 | $838,000 | -41.8% | 147,189 | 0.0% | 0.20% | -58.3% |
| Q4 2021 | $1,441,000 | -92.2% | 147,189 | -16.1% | 0.48% | -93.0% |
| Q3 2021 | $18,566,000 | +42.9% | 175,362 | +15.2% | 6.75% | +26.4% |
| Q2 2021 | $12,990,000 | -23.4% | 152,162 | +3.0% | 5.34% | -25.2% |
| Q1 2021 | $16,949,000 | -18.0% | 147,662 | 0.0% | 7.14% | -3.4% |
| Q4 2020 | $20,673,000 | +54.1% | 147,662 | -10.3% | 7.39% | +30.2% |
| Q3 2020 | $13,412,000 | +4.5% | 164,662 | -7.8% | 5.68% | -0.8% |
| Q2 2020 | $12,839,000 | +61.5% | 178,662 | 0.0% | 5.73% | +18.8% |
| Q1 2020 | $7,949,000 | -35.2% | 178,662 | +38.9% | 4.82% | -35.2% |
| Q4 2019 | $12,269,000 | – | 128,662 | – | 7.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |